Reviva Pharmaceuticals Holdings(RVPH)
$0.30+0.02 (+5.63%)
RVPH
Reviva Pharmaceuticals Holdings earnings date
$0.30
At close:+0.02 (+5.63%)
Want to see RVPH full AI Analyst Report?
Reviva Pharmaceuticals Holdings (RVPH) Q2 2026 Earnings Report
1,273 Followers
RVPH Q2 2026 EPS Results
- Actual EPS
- -$0.19
- Consensus EPS
- -$0.39
- Beat/Miss
- Beat by +$0.20
- One Year Ago EPS
- -$2.40
RVPH Q2 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/12/2026
- Time
- After Close
- Conference Call
- Wednesday, August 12, 2026
RVPH Upcoming Earnings
Reviva Pharmaceuticals Holdings's next earnings date is estimated for April 5, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
RVPH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 05, 2027 | 2026 (Q4) | -0.19- | -0.46 | ― | ― |
| Nov 13, 2026 | 2026 (Q3) | -0.29-0.17 | -1.2 | 85.83% (+1.03) | |
| Aug 12, 2026 | 2026 (Q2) | -0.39-0.19 | -2.4 | 92.08% (+2.21) | |
| May 13, 2026 | 2026 (Q1) | -0.35-0.46 | -2.6 | 82.31% (+2.14) | |
| Mar 30, 2026 | 2025 (Q4) | -1.080.72 | -2.8 | 125.71% (+3.52) | |
| Nov 13, 2025 | 2025 (Q3) | -1.90-1.20 | -5 | 76.00% (+3.80) | |
| Aug 14, 2025 | 2025 (Q2) | -2.35-2.40 | -5.2 | 53.85% (+2.80) | |
| May 15, 2025 | 2025 (Q1) | ―-0.13 | -5 | 97.40% (+4.87) | |
| Mar 31, 2025 | 2024 (Q4) | -3.94-2.60 | -5 | 48.00% (+2.40) | |
| Nov 14, 2024 | 2024 (Q3) | -4.88-5.00 | -8.8 | 43.18% (+3.80) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

